Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
American Fusion Inc. (OTC: AMFN) Appoints John Gerdin to Board of Directors as Independent Director and Strategic Advisor
GlobeNewswire, Inc.
SOUTHLAKE, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTC: AMFN) ("American Fusion" or the "Company"), developer of the proprietary Texatron™ Fusion Engine™, announced today that John Gerdin has been appointed to the Company’s...
Syncron Appoints Bianka Hay-Falk as Chief Human Resources Officer
GlobeNewswire, Inc.
STOCKHOLM, June 23, 2026 (GLOBE NEWSWIRE) -- Syncron, a global leader in intelligent aftermarket solutions, today announced the appointment of Bianka Hay-Falk as Chief Human Resources Officer.
Virella Files European Patent Application for Novel SIRT6 Small-Molecule Activators
EIN Presswire
Liechtenstein-based biotech company reports significant lifespan extension in C. elegans and advances toward preclinical development with CRO partners SCHAAN, LIECHTENSTEIN, April 3, 2026 /EINPresswire.com/ -- Virella Ltd, a European biotech...
The European Magazine Releases Its Summer 2026 Edition
EIN Presswire
The Summer 2026 edition of The European is out now. Order your print or digital copy for exclusive interviews, expert analysis and global insights.
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
GlobeNewswire, Inc.
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
GlobeNewswire, Inc.
BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...
Fire Stopping Materials Market worth $2.47 billion by 2030, at 5.7%, says MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, June 18, 2026 (GLOBE NEWSWIRE) -- In terms of value, the Fire Stopping Materials Market projected to grow from USD 1.87 billion in 2025 and to reach USD 2.47 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.7% during...
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
GlobeNewswire, Inc.
First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
GlobeNewswire, Inc.
New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) represents a rare achievement that reinforces the urgent...
Ambassador Hana Duke Ibrahimova Joins Youth Power Ventures Senior Leadership
GlobeNewswire, Inc.
New York, April 24, 2026 (GLOBE NEWSWIRE) -- Youth Power Ventures (YPV) is pleased to announce the appointment of Ambassador Hana Ibrahimova to its senior management team.
CEO Insight examines the strategies shaping global investment, finance and economic resilience
EIN Presswire
LONDON, UNITED KINGDOM, July 15, 2026 /EINPresswire.com/ -- The latest edition of CEO Insight explores how governments, financial institutions and business leaders are responding to a rapidly evolving global economy, where geopolitical...
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
GlobeNewswire, Inc.
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...
SEALSQ C-Suite Visits India to Advance Post-Quantum Semiconductor Personalization Center, Quantum Investments, and Sovereign Space Capabilities
GlobeNewswire, Inc.
Geneva, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today...
European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth
EIN Presswire
The European Commission’s authorization of Zandoriah®, an osteoporosis medication, marks a significant step in CinnaGen’s journey of international expansion DUBAI, DUBAI, UNITED ARAB EMIRATES, July 3, 2026 /EINPresswire.com/ -- July 02, 2026:...
Stamp Day Marks Day One of "Macao 2026" as International Experts Unveil the Wonders of the Miniature World
Macao Government News
MACAU, June 26 - On 26 June, the Macao 2026 Specialized World Stamp Exhibition officially commenced, kicking off the six-day philatelic extravaganza with “Stamp Day” as its opening theme.
Bitcoin Suisse Moves Its Ethereum Staking to Obol Distributed Validators
EIN Presswire
Switzerland's native premium crypto financial service provider is transitioning to operating its Ethereum validators on Obol Distributed Validators.
Open Cosmos Announces ConnectedCosmos: A European Alternative for Secure Space-Based Connectivity & Operational Resilience
GlobeNewswire, Inc.
New LEO constellation represents major step for UK and European space industry Empowers nations and partners with resilient, real-time intelligence and protected space-based connectivity BARCELONA, Spain, March 02, 2026 (GLOBE NEWSWIRE) -- Open...
Introducing Obyte Friends: Rewards for Connections and Active Staking
EIN Presswire
Obyte community members can now make 1% a day by making friends every day and spreading the word about Obyte's unstoppable, censorship-resistant tech TRIESEN, LIECHTENSTEIN, January 2, 2026 /EINPresswire.com/ -- Obyte, the DAG-based...
Alex Lawton Becomes CEO of Clear Street U.K. Following FCA Approval
GlobeNewswire, Inc.
LONDON, May 06, 2026 (GLOBE NEWSWIRE) -- Clear Street ("Clear Street" or "the Company"), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access to every asset in every market, through a unified...
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
GlobeNewswire, Inc.
REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...
Sign up for:
Technology Week Liechtenstein
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.